COVID-19 frequency and clinical course in children with asthma

Table 4 Evaluation of pathologic laboratory parameters in different groups of our asthma patients

	Others1, (n = 169)	Vaccinated patients (n = 57)	Atopic patients (n = 64)	P value	ES
Leukopenia (< 4000)	8/67 (11.9)	2/12 (16.7)	4/17 (23.5)	0.541	0.125
Leukocytosis (> 10000)	11/67 (16.4)	0/12 (0)	1/17 (5.9)	0.193	0.186
Neutropenia (< 1500)	6/67 (9)	1/12 (8.3)	1/17 (5.9)	1.000	0.042
Neutrophilia (> 7500)	10/67 (14.9)	0/12 (0)	2/17 (11.8)	0.447	0.147
Lymphopenia (< 1500)	29/68 (42.6)	5/12 (41.7)	10/17 (58.8)	0.470	0.125
Lymphocytosis (> 4000)	3/68 (4.4)	0/12 (0)	2/17 (11.8)	0.475	0.152
Eosinophilia (> 500)	4/67 (6)	1/12 (8.3)	1/17 (5.9)	1.000	0.033
Thrombocytopenia (< 150000)	5/68 (7.4)	0/12 (0)	1/17 (5.9)	0.832	0.099
Thrombocytosis (> 450000)	1/68 (1.5)	0/12 (0)	0/17 (0)	1.000	0.067
Elevated CRP (> 3)	42/62 (67.7)	7/8 (87.5)	6/14 (42.9)	0.090	0.245
Elevated sedimentation (> 20)	1/5 (20)	0/2 (0)	-	1.000	0.258
Elevated AST (> 50)	2/63 (3.2)	0/12 (0)	1/16 (6.3)	1.000	0.097
Elevated ALT (> 50)	3/63 (4.8)	1/12 (8.3)	1/16 (6.3)	1.000	0.054
Elevated urea (> 45)	0/61	0/12	0/16	-	-
Elevated PT (>13.2)	3/33 (9.1)	0/4 (0)	2/8 (25)	0.261	0.221
Elevated aPTT (> 33.5)	2/31 (6.5)	0/4 (0)	0/7 (0)	1.000	0.133
Elevated D-dimer (> 500)	6/48 (12.5)	1/9 (11.1)	1/11 (9.1)	1.000	0.039
Elevated LDH (> 248)	15/47 (31.9)	2/8 (25)	4/12 (33.3)	1.000	0.052
Elevated total IgE (> 150)	10/37 (27)	1/2 (50)	9/13 (69.2)	0.019	0.376

¹This column includes asthma patients who are neither atopic nor vaccinated.

Statistics were shown as n/total n (%). ES: Effect size (Cramer v coefficient).